NPI: 1104187202 · SAN JOSE, CA 95131 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/05/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/05/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,452 | $153K |
| 2019 | 8,649 | $146K |
| 2020 | 8,379 | $141K |
| 2021 | 6,051 | $109K |
| 2022 | 7,433 | $123K |
| 2023 | 4,045 | $107K |
| 2024 | 3,934 | $297K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 14,614 | 1,906 | $946K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,654 | 1,162 | $88K |
| J1756 | Injection, iron sucrose, 1 mg | 2,577 | 728 | $16K |
| A4657 | Syringe, with or without needle, each | 3,793 | 953 | $13K |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,170 | 859 | $7K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 259 | 152 | $5K |
| 83970 | 131 | 117 | $117.78 | |
| 82728 | 112 | 101 | $40.61 | |
| 90674 | 12 | 12 | $36.30 | |
| 83550 | 112 | 101 | $23.33 | |
| 85041 | 267 | 243 | $22.92 | |
| 83540 | 112 | 101 | $19.37 | |
| 85048 | 260 | 237 | $18.42 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 26 | 24 | $17.50 |
| 82108 | 15 | 15 | $14.44 | |
| 0250 | 789 | 50 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 40 | 26 | $0.00 |